No Picture
News

Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia

High content screen identifies fostamatinib as a candidate for repurposing for Acute Lung Injury

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the initiation of an investigator-s… […]

No Picture
News

IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will parti… […]

No Picture
News

MedTech Innovator Selects 20 Startups for Annual Asia Pacific Accelerator and Announces Extended Asia Pacific Partnership With Johnson & Johnson

LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to… […]

No Picture
News

Peninsula biotech spins out parasite-fighting drugs to biotech legends’ startup

A Peninsula biotech company is supplying a set of parasite-fighting preclinical compounds to a startup created by one of the scientists who co-founded the company more than two decades ago.

Kainomyx Inc. — launched by a Stanford University-connected t… […]

No Picture
News

‘We’ve got to hammer that home’: Tony Fauci talks Covid-19 response, promise of therapies, vaccines

As Foster City-based Gilead Sciences moves forward with remdesivir and other Bay Area companies pursue new or repurposed drugs and vaccines against Covid-19 and the coronavirus that causes the disease, NIAID chief Dr. Tony Fauci talked in a webinar wit… […]

No Picture
News

89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases,… […]